⸺ Synova Research
Selank
Synthetic tuftsin analogue studied in animal models for anxiolytic signalling, immune modulation and cognitive endpoints.
Secure checkout via UK open banking. Free shipping on orders over £100.
Independently tested
COA on request
Next-day UK dispatch
Order before midnight
Research use only
Not for human consumption
⸺ Important
- • Peptides sold in lyophilized form
- • Strictly for laboratory research
⸺ Overview
About Selank
Selank is a synthetic heptapeptide analogue of the immune peptide tuftsin. Preclinical research examines its effects on GABAergic and serotonergic signalling, alongside immune-modulating and nootropic endpoints.
⸺ Mechanism of Action
How it works
Selank appears to modulate GABA and serotonin activity and influence enkephalin breakdown, producing calming effects in animal models without sedation or dependence signalling. It also alters expression of immune cytokines such as interleukin-6.
⸺ Research
Areas of study
Anxiety-related models
Rodent studies report reduced anxiety-like behaviour without sedative or withdrawal effects.
Cognition and memory
Preclinical work examines learning and memory endpoints linked to BDNF and monoamine signalling.
Immune modulation
Research describes changes in cytokine expression consistent with its tuftsin-derived structure.
Summarised from preclinical literature for informational purposes only. Not medical or veterinary advice. Synova Research products are sold strictly for in-vitro and laboratory research.
⸺ Details
Specification
- CAS
- 129954-34-3
- Intended use
- Research use only.
- Storage
- Lyophilised: cool, dry, dark. Reconstituted: refrigerate at 2–8°C.
- Solubility
- Vial holds up to 3mL.
- Shelf life
- Lyophilised: up to 24 months. Reconstituted: 4–6 weeks refrigerated.
- Handling
- Maintain sterile technique.
You might also research
View all →
R3TA
Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied in animal models for appetite control, energy expenditure and glucose balance.
T1RZ
Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.
Semaglutide
Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.